M
$ Value
$0
Shares
972
Price
$0
Filed
Feb 27
Insider
Name
Weiner David B.
Title
—
CIK
0001669080
Roles
Director
Transaction Details
Transaction Date
2026-02-26
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Filing Info
Weiner David B.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-26 | INO | M | — |
| 2026-02-26 | INO | M | $0 |
| 2025-05-21 | INO | M | — |
| 2025-05-21 | INO | M | $0 |
Other Insiders at INO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
KIES PETER
CFO
|
— | — | 2026-03-04 |
| Weiner David B. | — | — | 2026-02-26 |
|
Humeau Laurent
Chief Scientific Officer
|
— | — | 2026-03-04 |
|
Shea Jacqueline Elizabeth
Chief Executive Officer
|
— | — | 2026-03-04 |
|
Sumner Michael John
Chief Medical Officer
|
— | — | 2026-03-31 |